Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#171 / 200 Total
CORZ - Core Scientific Inc - Stock Price Chart
TickerCORZ [NASD]
CompanyCore Scientific Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap680.90MEPS (ttm)0.11
P/E36.37EPS this Y163.08%
Forward P/E15.02EPS next Y-37.80%
PEG-EPS past 5Y-
P/S1.21EPS next 5Y-
P/B-EPS Q/Q2497.75%
Dividend-Sales Q/Q48.60%
Insider Own11.33%Inst Own15.63%
Insider Trans1.95%Inst Trans-
Short Float5.64%EarningsMay 08/a
Analyst Recom1.67Target Price6.75
Avg Volume3.36M52W Range2.61 - 6.10
Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sterling Denise Marie BruciaChief Financial OfficerMay 13 '24Sale3.664,26115,595130,969May 15 04:02 PM
Becker Todd ADirectorMar 15 '24Buy3.16130,000410,163134,250Mar 19 04:17 PM
Patten Jarrod MDirectorMar 15 '24Buy3.32100,000332,220100,000Mar 19 04:17 PM
Rozov YadinDirectorMar 15 '24Buy3.0780,000245,96880,000Mar 18 07:45 PM
Sullivan Adam TaylorChief Executive OfficerMar 15 '24Buy3.0665,300199,96293,753Mar 18 07:46 PM
BWEN - Broadwind Inc - Stock Price Chart
TickerBWEN [NASD]
CompanyBroadwind Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap56.56MEPS (ttm)0.39
P/E6.72EPS this Y-84.72%
Forward P/E6.74EPS next Y604.55%
PEG0.28EPS past 5Y-
P/S0.29EPS next 5Y24.00%
P/B0.99EPS Q/Q92.22%
Dividend-Sales Q/Q-23.03%
Insider Own12.20%Inst Own27.77%
Insider Trans0.38%Inst Trans20.91%
Short Float1.00%EarningsMay 14/b
Analyst Recom1.00Target Price6.00
Avg Volume91.71K52W Range2.01 - 5.05
Broadwind, Inc. is engaged in the manufacture of structures, equipment, and components for clean tech and other specialized applications. It operates through the following business segments: Heavy Fabrications, Gearing and Industrial Solutions. The Heavy Fabrications segment provides fabrications to customers in industrial markets. The Gearing segment provides gearing and gearboxes to customers in diverse markets including onshore and offshore oil and gas (O&G) fracking and drilling, surface and underground mining, wind energy, steel, material handling and other industrial markets. The Industrial Solutions segment provides supply chain solutions, inventory management, and kitting and assembly services, primarily serving the combined cycle natural gas turbine market. The company was founded in 1996 and is headquartered in Cicero, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shivaram Sachin MDirectorNov 16 '23Buy2.1810,00021,80064,512Nov 20 05:01 PM
Wagner Thomas A.DirectorSep 06 '23Sale3.9910,00039,92683,683Sep 08 05:01 PM
Kennedy Hayes M.Chief Human Resources OfficerAug 21 '23Buy3.862,5009,65332,725Aug 23 05:02 PM
Press Jeanette A.DirectorAug 21 '23Buy3.9225098013,813Aug 23 05:04 PM
Shivaram Sachin MDirectorAug 18 '23Buy3.6725,94095,24654,512Aug 21 04:42 PM
NRSN - NeuroSense Therapeutics Ltd - Stock Price Chart
TickerNRSN [NASD]
CompanyNeuroSense Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap20.76MEPS (ttm)-0.85
P/E-EPS this Y3.61%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-7.06%
P/S-EPS next 5Y-
P/B-EPS Q/Q28.27%
Dividend-Sales Q/Q-
Insider Own36.03%Inst Own1.03%
Insider Trans0.00%Inst Trans-58.47%
Short Float0.16%EarningsApr 05/b
Analyst Recom1.00Target Price7.50
Avg Volume288.33K52W Range0.40 - 2.33
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer's and Parkinson's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
DRIO - DarioHealth Corp - Stock Price Chart
TickerDRIO [NASD]
CompanyDarioHealth Corp
CountryUSA
IndustryHealth Information Services
Market Cap54.89MEPS (ttm)-1.96
P/E-EPS this Y50.95%
Forward P/E-EPS next Y69.89%
PEG-EPS past 5Y34.16%
P/S2.88EPS next 5Y-
P/B0.70EPS Q/Q55.46%
Dividend-Sales Q/Q-18.51%
Insider Own17.02%Inst Own28.81%
Insider Trans0.00%Inst Trans-10.65%
Short Float5.47%EarningsMay 15/b
Analyst Recom1.00Target Price5.67
Avg Volume129.51K52W Range0.68 - 4.58
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
PSTV - Plus Therapeutics Inc - Stock Price Chart
TickerPSTV [NASD]
CompanyPlus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap9.93MEPS (ttm)-4.50
P/E-EPS this Y43.16%
Forward P/E-EPS next Y0.69%
PEG-EPS past 5Y68.20%
P/S2.02EPS next 5Y-
P/B-EPS Q/Q66.65%
Dividend-Sales Q/Q769.54%
Insider Own2.06%Inst Own2.43%
Insider Trans120.69%Inst Trans-3.62%
Short Float1.10%EarningsMay 15/a
Analyst Recom1.00Target Price19.33
Avg Volume70.61K52W Range0.97 - 4.45
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEDRICK MARC HChief Executive OfficerMay 08 '24Buy2.0412,25525,00012,425May 10 07:30 AM
Petersen GregDirectorMay 08 '24Buy2.0412,25525,00036,421May 10 07:30 AM
Clowes HowardDirectorMay 08 '24Buy2.049,80420,00021,497May 10 07:30 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerMay 08 '24Buy2.044,90210,0005,717May 10 07:30 AM
Hawkins Richard JDirectorMay 08 '24Buy2.044,90210,0004,903May 10 07:30 AM
NXT - Nextracker Inc - Stock Price Chart
TickerNXT [NASD, RUT]
CompanyNextracker Inc
CountryUSA
IndustrySolar
Market Cap6.28BEPS (ttm)1.65
P/E27.79EPS this Y-1.37%
Forward P/E13.52EPS next Y12.65%
PEG0.69EPS past 5Y-
P/S2.51EPS next 5Y40.20%
P/B-EPS Q/Q-93.00%
Dividend-Sales Q/Q42.08%
Insider Own4.74%Inst Own90.18%
Insider Trans-62.90%Inst Trans-
Short Float9.38%EarningsMay 14/a
Analyst Recom1.43Target Price62.13
Avg Volume3.20M52W Range32.14 - 62.14
May-15-24Upgrade Fox Advisors Equal Weight → Overweight $60
Nextracker, Inc. engages in the provision of integrated solar tracker and software solutions used in utility-scale and ground-mounted distributed generation solar projects. Its products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. The company was founded by Daniel S. Shugar, Alexander Au, Nicholas Miller, Michael Mehavich, Marco Garcia, and Tyroan Hardy in 2013 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schlesinger LeahGC, Ch Eth & Compl Off'r & SecApr 03 '24Sale51.912,149111,55511,910Apr 03 08:15 PM
Miller Nicholas MarcoChief Operating OfficerApr 02 '24Sale52.678,355440,02411,114Apr 03 08:07 PM
TPG GP A, LLC10% OwnerFeb 05 '24Sale56.6011,000,000622,600,0006,044,918Feb 07 04:44 PM
SHUGAR DANIEL SChief Executive OfficerDec 07 '23Buy39.6337,8211,498,82377,713Dec 08 04:05 PM
Schlesinger LeahGC, Ch Eth & Compl Off'r & SecNov 20 '23Sale40.002,19287,6805,114Nov 21 04:03 PM
NVRO - Nevro Corp - Stock Price Chart
TickerNVRO [NYSE, RUT]
CompanyNevro Corp
CountryUSA
IndustryMedical Devices
Market Cap387.87MEPS (ttm)-2.28
P/E-EPS this Y9.31%
Forward P/E-EPS next Y8.89%
PEG-EPS past 5Y-9.37%
P/S0.90EPS next 5Y-
P/B1.39EPS Q/Q29.22%
Dividend-Sales Q/Q5.78%
Insider Own4.87%Inst Own97.60%
Insider Trans0.00%Inst Trans-1.53%
Short Float11.08%EarningsMay 07/a
Analyst Recom3.28Target Price15.22
Avg Volume519.68K52W Range9.76 - 28.89
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCormick ShawnDirectorJun 07 '23Buy22.887,500171,63326,866Jun 09 04:37 PM
XYLO - Xylo Technologies Ltd. ADR - Stock Price Chart
TickerXYLO [NASD]
CompanyXylo Technologies Ltd. ADR
CountryIsrael
IndustryMedical Devices
Market Cap3.78MEPS (ttm)-9.62
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.16%
P/S0.04EPS next 5Y-
P/B0.16EPS Q/Q-1104.85%
Dividend-Sales Q/Q-36.36%
Insider Own0.06%Inst Own0.18%
Insider Trans0.00%Inst Trans-44.19%
Short Float0.18%Earnings-
Analyst Recom1.00Target Price1350.00
Avg Volume14.90K52W Range1.50 - 7.17
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.
SBSW - Sibanye Stillwater Limited ADR - Stock Price Chart
TickerSBSW [NYSE]
CompanySibanye Stillwater Limited ADR
CountrySouth Africa
IndustryGold
Market Cap3.85BEPS (ttm)-2.84
P/E-EPS this Y150.85%
Forward P/E7.60EPS next Y114.20%
PEG-EPS past 5Y-54.04%
P/S0.62EPS next 5Y-
P/B1.44EPS Q/Q-756.46%
Dividend1.87%Sales Q/Q-27.53%
Insider Own0.13%Inst Own15.10%
Insider Trans0.00%Inst Trans5.84%
Short Float2.64%EarningsMar 05/b
Analyst Recom3.62Target Price5.20
Avg Volume6.71M52W Range3.85 - 8.01
May-10-24 12:29PM Basic Materials Roundup: Market Talk (The Wall Street Journal)
May-09-24 09:40AM Is Sibanye Gold Limited (SBSW) Stock Undervalued Right Now? (Zacks) +8.37%
May-07-24 06:00AM Inflation Fighters: 3 Cheap Gold Stocks to Buy Now (InvestorPlace)
May-03-24 06:00AM 3 Mining Stocks That Can Extract Long-Term Gains for Savvy Investors (InvestorPlace)
Apr-29-24 12:16PM 20 Countries That Produce the Most Gold in the World (Insider Monkey)
06:00AM 3 Value Stocks to Buy on the Dip: April 2024 (InvestorPlace)
Apr-23-24 09:40AM Is Sibanye Gold Limited (SBSW) a Great Value Stock Right Now? (Zacks)
Apr-13-24 01:52PM 12 Best Precious Metals Stocks to Invest In Now (Insider Monkey)
Mar-27-24 10:46AM 30 Least Developed Countries and Their Characteristics (Insider Monkey)
Mar-20-24 02:58PM 30 Countries With the Lowest GDP Per Capita in the World (Insider Monkey) +9.66%
Sibanye Stillwater Ltd. engages in the acquisition and exploration of platinum group materials. It operates through the following segments: US PGM, SA PGM, and US Gold. The company was founded on November 7, 2014 and is headquartered in Weltevreden Park, South Africa.
RLAY - Relay Therapeutics Inc - Stock Price Chart
TickerRLAY [NASD, RUT]
CompanyRelay Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap901.97MEPS (ttm)-2.64
P/E-EPS this Y-1.73%
Forward P/E-EPS next Y0.65%
PEG-EPS past 5Y-38.74%
P/S25.53EPS next 5Y-
P/B1.21EPS Q/Q19.93%
Dividend-Sales Q/Q4327.88%
Insider Own29.70%Inst Own72.30%
Insider Trans-0.05%Inst Trans1.51%
Short Float12.35%EarningsMay 02/a
Analyst Recom1.09Target Price23.10
Avg Volume1.21M52W Range5.70 - 13.32
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergstrom Donald APresident, R&DApr 29 '24Sale6.382,68617,137527,427Apr 29 08:30 PM
Catinazzo ThomasChief Financial OfficerApr 29 '24Sale6.381,69510,814339,803Apr 29 08:31 PM
Adams BrianChief Legal OfficerApr 29 '24Sale6.381,62310,355325,767Apr 29 08:33 PM
Rahmer PeterSee remarksApr 29 '24Sale6.381,3458,581513,334Apr 29 08:36 PM
Bergstrom Donald APresident, R&DMar 27 '24Sale7.707655,890530,113Mar 29 04:15 PM
1101314151617181920